8-K: Profound Medical to Announce Q2 2026 Results August 6

Profound Medical Corp. announced plans to release its second quarter 2026 financial results on August 6, 2026, followed by a conference call.

Summary

• Profound Medical Corp. will announce its financial results for the second quarter of 2026 after the market closes on Thursday, August 6, 2026.
• A conference call to discuss these results and business developments is scheduled for the same day at 4:30 p.m. Eastern Time.
• The company is a commercial-stage medical device company focused on interventional MRI (iMRI) procedures.
• Its flagship platform, TULSA-PRO, offers MRI-guided, incision-free prostate ablation.
• Profound also commercializes Sonalleve, an MRI-guided therapy for pain palliation and gynecologic conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral announcement, primarily serving as a notification for upcoming financial results and a conference call, without providing new financial data or strategic updates.

Positives

• Profound Medical is a commercial-stage medical device company with innovative iMRI procedures.
• TULSA-PRO offers a personalized, incision-free treatment for prostate care, minimizing side effects.
• Sonalleve provides a non-surgical treatment option for various conditions, including uterine fibroids and adenomyosis, potentially preserving fertility.
• Profound's technologies are approved in major global markets, including FDA clearance for TULSA-PRO and Sonalleve in the US for specific indications.

Future Outlook

The company will host a conference call to review financial results and discuss business developments for the second quarter of 2026.

Industry Context

StockSavvy.ai notes that Profound Medical operates in the growing medical device sector, specifically focusing on advanced MRI-guided therapies. The company's focus on minimally invasive procedures aligns with industry trends towards less invasive treatments and personalized medicine.

Stakeholder Impact

• Shareholders: Will receive updated financial performance information for the second quarter of 2026.
• Investors: Will have an opportunity to gain insights into the company's business developments during the conference call.

Next Steps

• Release of second quarter 2026 financial results after market close on August 6, 2026.
• Host a conference call at 4:30 p.m. ET on August 6, 2026, to review financial results and discuss business developments.

Key Dates

Keywords

Profound Medical Corp., 8-K Filing, Financial Results, Q2 2026, Medical Device, iMRI, TULSA-PRO, Sonalleve